502 on NobleID · 30 being added
| Title | Cited by | Year |
|---|---|---|
| 5,349 | 2018 | |
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma New England Journal of Medicine | 3,387 | 2017 |
| 1,368 | 2019 | |
| 1,254 | 2018 | |
| 1,113 | 1999 |
Creating an account is free.
For data access, contact info@nobleid.org.
